AGENDA & REGISTRATION:
CENTER FOR MEDICAL PROGRESS
Prescription for Progress: The Critical Path for Drug Development by Robert Goldberg, PhD and Peter Pitts
M Street Hotel 1143 New Hampshire Avenue, N.W. Washington, D.C. Thursday, June 8, 2006
Keynote Speaker:
Andrew C. von Eschenbach, M.D. Acting Commissioner, U.S. Food and Drug Administration
The U.S. Food and Drug Administration (FDA) is taking steps to streamline drug development by incorporating new technologies, including genetic tools, faster computers, new imaging techniques, and electronic medical records, into the drug evaluation process. This program, the Critical Path Initiative, while still in its infancy, holds the potential to break down barriers between regulators and industry and to expedite the journey of lifesaving medical innovations from researchers to regulators to patients.
In support of the Critical Path Initiative, the Center for Medical Progress at the Manhattan Institute convened experts with wideranging experience across industry, government, and the scientific community in a task force on the 21st century FDA. This working paper reflects the Task Force's discussions on how advances in genomics and other disciplines might be used to optimize the drug approval process, and what tools and resources the FDA needs to achieve this outcome.
Confirmed participants include Scott Gottlieb, M.D., Deputy Commissioner for Medical and Scientific Affairs, FDA; Janet Woodcock, M.D., Deputy Commissioner for Operations, FDA; and Peter Hotez, M.D., Ph.D., Professor and Chair, Department of Microbiology, Immunology and Tropical Medicine, George Washington University Medical Center.
Please join us as we discuss how the biomedical research community can help advance the next generation of medical miracles.
Name:
Affiliation:
Phone:
Email:
Please, check the sessions you will attend:
8:30-9:00 AM
Registration
9:00-9:10 AM
Introduction and Overview
Robert Goldberg, Ph.D., Chairman, 21st Century FDA Task Force, Vice President & Co-Founder, Center for Medicine in the Public Interest Peter Pitts, Director, Center for Medicine in the Public Interest
9:10-10:00 AM
Keynote Address Keynote: Andrew von Eschenbach, M.D., Acting Commissioner, FDA
10:00-11:00 AM
Panel 1: Roundtable on Prescription for Progress: The Critical Path to Drug Development
Moderator: Michael Weber, M.D., Professor of Medicine, SUNY Downstate College of Medicine Panelists: Jeffrey Cossman, M.D., Chief Scientific Officer, The Critical Path Institute Gualberto Ruano, M.D., Ph.D., President, Genomas, and Director of Cardiovascular Research, Hartford Hospital Robert McBurney, Ph.D., Senior Vice President, Research and Development, and Chief Scientific Officer, BG Medicine, Inc. Scott Gottlieb, M.D., Deputy Commissioner for Medical and Scientific Affairs, FDA
11:00-11:10 AM
Break
11:10-12:15 PM
Panel II: The Critical Path Today and Tomorrow: Challenges and Opportunities Moderator: Steve Usdin, Senior Editor, BioCentury Publications Panelists: Janet Woodcock, M.D., Deputy Commissioner for Operations, FDA Meryl Comer, Patient Advocate for Alzheimer’s Research Peter Hotez, Ph.D, M.D., Professor and Chair, Department of Microbiology, Immunology and Tropical Medicine, George Washington University Medical Center
YOU ARE CORDIALLY INVITED TO ATTEND. THERE IS NO CHARGE, But if you accept and find you are unable to attend, please be sure to let us know.
If you have any problems submitting your registration online, please contact Taisha Camacho, Event Coordinator, 212-599-7000 or tcamacho@manhattan-institute.org.
